Per Johansson
1 – 20 of 47
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Development of the Swedish anticholinergic burden scale (Swe-ABS)
(
- Contribution to journal › Article
-
Mark
Sex steroid levels in corresponding cerebrospinal fluid and serum samples quantified by mass spectrometry in men
(
- Contribution to journal › Article
- 2022
-
Mark
Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults : Effects of Alzheimer's Disease Pathology and Cognitive Decline
(
- Contribution to journal › Article
-
Mark
Testosterone associates differently with body mass index and age in serum and cerebrospinal fluid in men
(
- Contribution to journal › Letter
-
Mark
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
(
- Contribution to journal › Article
- 2021
-
Mark
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study : CSF/s-T4 associated with QoL in hypothyroidism
(
- Contribution to journal › Article
-
Mark
Apathy and anxiety are early markers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
2020) In Neuron(
- Contribution to journal › Article
- 2019
-
Mark
Inför specialistutbildning i kognitiv medicin för läkare
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk
(
- Contribution to journal › Article
- 2018
-
Mark
Cognitive medicine - a new approach in health care science
(
- Contribution to journal › Article
- 2017
-
Mark
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
2017) In NeuroMolecular Medicine(
- Contribution to journal › Article
-
Mark
Psychometric testing of a Swedish version of the Apathy Evaluation Scale
(
- Contribution to journal › Article
-
Mark
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
(
- Contribution to journal › Article
-
Mark
The TECH@HOME study, a technological intervention to reduce caregiver burden for informal caregivers of people with dementia : study protocol for a randomized controlled trial
(
- Contribution to journal › Article
- 2016
-
Mark
Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease
(
- Contribution to journal › Article